Global health research and education at medical faculties in Germany.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 12 03 2019
accepted: 20 03 2020
entrez: 21 4 2020
pubmed: 21 4 2020
medline: 21 7 2020
Statut: epublish

Résumé

Universities undertake the majority of publicly funded research in Germany and hence bear a responsibility to contribute to global health efforts. So far, involvement and impact of German medical faculties in global health are unknown. Our aim was to systematically asses and evaluate German medical faculties' contribution to global health related research and education, as well as their policies and practices concerning open access publishing and equitable licensing. We assessed the involvement in global health of all 36 publicly funded medical faculties in Germany during 2010-2014 in three areas: innovation, access and education, using the following indicators: research funding and publications focused on global health or poverty-related and neglected diseases; open access publishing and policies promoting access to medical innovations worldwide; provision of global health education. Data were gathered from public databases, university websites and questionnaires sent to individual universities for validation and triangulation. There was a high level of variability between institutions and indicators. The proportion of research funding for poverty-related and neglected diseases research ranged between 0.0-1.1%. The top five institutions received nearly 85% of the total poverty-related and neglected diseases research funding. 20 of 36 universities had an institutional open access publishing policy, 19 had an open access publishing fund, 16 had neither. Only one university reported having used an equitable licensing policy. 22 of 36 faculties provided some global health education, but only one of them included global health in their core undergraduate medical curriculum as a compulsory course with more than just single lectures. Obtained data indicate that global health and poverty-related and neglected diseases research at German medical faculties is highly concentrated in a few institutions, open-access publishing and equitable licensing policies are mostly absent, and only little global health education exists. Universities and government should address global health strategically in both research and education at medical faculties to reflect the country's economic and political weight and human resource potential.

Sections du résumé

BACKGROUND
Universities undertake the majority of publicly funded research in Germany and hence bear a responsibility to contribute to global health efforts. So far, involvement and impact of German medical faculties in global health are unknown. Our aim was to systematically asses and evaluate German medical faculties' contribution to global health related research and education, as well as their policies and practices concerning open access publishing and equitable licensing.
METHODS
We assessed the involvement in global health of all 36 publicly funded medical faculties in Germany during 2010-2014 in three areas: innovation, access and education, using the following indicators: research funding and publications focused on global health or poverty-related and neglected diseases; open access publishing and policies promoting access to medical innovations worldwide; provision of global health education. Data were gathered from public databases, university websites and questionnaires sent to individual universities for validation and triangulation.
RESULTS
There was a high level of variability between institutions and indicators. The proportion of research funding for poverty-related and neglected diseases research ranged between 0.0-1.1%. The top five institutions received nearly 85% of the total poverty-related and neglected diseases research funding. 20 of 36 universities had an institutional open access publishing policy, 19 had an open access publishing fund, 16 had neither. Only one university reported having used an equitable licensing policy. 22 of 36 faculties provided some global health education, but only one of them included global health in their core undergraduate medical curriculum as a compulsory course with more than just single lectures.
CONCLUSION
Obtained data indicate that global health and poverty-related and neglected diseases research at German medical faculties is highly concentrated in a few institutions, open-access publishing and equitable licensing policies are mostly absent, and only little global health education exists. Universities and government should address global health strategically in both research and education at medical faculties to reflect the country's economic and political weight and human resource potential.

Identifiants

pubmed: 32310987
doi: 10.1371/journal.pone.0231302
pii: PONE-D-19-07156
pmc: PMC7170220
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0231302

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2015 Dec 31;9(12):e0004182
pubmed: 26719978
Lancet. 2018 Feb 17;391(10121):656-657
pubmed: 29617264
Lancet. 2013 Apr 13;381(9874):1248
pubmed: 23582382
BMC Med Educ. 2016 Nov 25;16(1):304
pubmed: 27884194
Glob Health Action. 2015 Jan 22;8:25818
pubmed: 25623607
Sci Transl Med. 2014 Oct 29;6(260):260cm11
pubmed: 25355695
PLoS Negl Trop Dis. 2010 Mar 30;4(3):e570
pubmed: 20361025
Lancet. 2013 Nov 23;382(9906):1702-3
pubmed: 24267997
BMC Med Educ. 2010 Oct 08;10:66
pubmed: 20932277
Lancet. 2009 Jun 6;373(9679):1993-5
pubmed: 19493564
Lancet. 2017 Aug 26;390(10097):898-912
pubmed: 28684024
Health Res Policy Syst. 2016 Oct 10;14(1):76
pubmed: 27724907

Auteurs

Léonie Karduck (L)

Institute for the History, Theory and Ethics of Medicine, RWTH Aachen University, Aachen, Germany.

Anna Lisa Behnke (AL)

The Berlin Institute of Health, Charité -Universitätsmedizin Berlin, Berlin, Germany.
The Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Berlin, Germany.
The Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany.
Universities Allied for Essential Medicines Europe e.V., Berlin, Germany.

Alicia Baier (A)

The Berlin Institute of Health, Charité -Universitätsmedizin Berlin, Berlin, Germany.
The Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Berlin, Germany.
The Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany.
Universities Allied for Essential Medicines Europe e.V., Berlin, Germany.

Dzintars Gotham (D)

Universities Allied for Essential Medicines Europe e.V., Berlin, Germany.
Independent, Boston, Massachusetts, United States of America.

Peter Grabitz (P)

The Berlin Institute of Health, Charité -Universitätsmedizin Berlin, Berlin, Germany.
The Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Berlin, Germany.
The Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany.
Universities Allied for Essential Medicines Europe e.V., Berlin, Germany.

Nora Lennartz (N)

Universities Allied for Essential Medicines Europe e.V., Berlin, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Lara Speer (L)

The Berlin Institute of Health, Charité -Universitätsmedizin Berlin, Berlin, Germany.
The Berlin Institute of Health, Corporate Member of Freie Universität Berlin, Berlin, Germany.
The Berlin Institute of Health, Humboldt-Universität zu Berlin, Berlin, Germany.
Universities Allied for Essential Medicines Europe e.V., Berlin, Germany.

Peter Tinnemann (P)

Institute for Social Medicine, Epidemiology and Health Economics, Germany.

Walter Bruchhausen (W)

Institute for the History and Ethics of Medicine, University of Cologne, Cologne, Germany.
Centre for Development Research, University of Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH